California Moves to Rein In AI “Therapists” as Mental Health Risks Mount
California lawmakers are moving to impose new restrictions on artificial-intelligence chatbots used for emotional support and mental-health advice, responding to growing concerns that people—particularly teenagers and vulnerable users—are increasingly treating AI companions as substitutes for professional therapists. The debate highlights a difficult challenge for regulators: AI systems can provide inexpensive and immediately available support, but […]
Grail’s Galleri Cancer Test Faces Landmark FDA Review After Mixed Clinical Results
Grail’s ambitious effort to transform cancer screening is approaching a pivotal regulatory moment. The U.S. Food and Drug Administration has scheduled an advisory committee meeting for September 23, 2026, to evaluate the company’s Galleri multi-cancer early detection blood test. It will be the first FDA advisory panel convened to consider a premarket approval application for […]
America Turns to Arkansas Lithium in Push to Break China’s Grip on Critical Minerals
Arkansas is emerging as a potentially important player in America’s effort to build a domestic lithium industry and reduce its dependence on China for one of the most strategically important minerals of the energy and technology economy. Beneath southern Arkansas lies the Smackover Formation, a geological formation containing lithium-rich underground brines that companies and state […]
